O'Neil Thomas P.
Insider CIK 1640645 · PTGX Chief Financial Officer · STSA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 60,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 80,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 190,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 76,595 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 72,340 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | U Tender | 2023-06-06 | 2023-06-08 | 13,877 | $0.91 | $12.6K | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2022-06-03 | 2022-06-07 | 190,000 | — | $0 | 190,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-12-03 | 2020-12-07 | 80,000 | — | $0 | 80,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise deriv | 2020-09-01 | 2020-09-03 | 750 | — | $0 | 65,590 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | S Sale | 2020-09-01 | 2020-09-03 | 750 | $22.19 | $16.6K | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise | 2020-09-01 | 2020-09-03 | 750 | $4.56 | $3.4K | 750 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise deriv | 2020-08-05 | 2020-08-07 | 1,000 | — | $0 | 66,340 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise | 2020-08-05 | 2020-08-07 | 1,000 | $4.56 | $4.6K | 1,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | S Sale | 2020-08-05 | 2020-08-07 | 1,000 | $25.00 | $25.0K | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise deriv | 2020-07-01 | 2020-07-02 | 1,000 | — | $0 | 67,340 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise | 2020-07-01 | 2020-07-02 | 394 | $4.56 | $1.8K | 394 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise | 2020-07-01 | 2020-07-02 | 300 | $4.56 | $1.4K | 300 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | S Sale | 2020-07-01 | 2020-07-02 | 300 | $25.63 | $7.7K | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | S Sale | 2020-07-01 | 2020-07-02 | 394 | $26.70 | $10.5K | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | S Sale | 2020-07-01 | 2020-07-02 | 306 | $27.59 | $8.4K | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise | 2020-07-01 | 2020-07-02 | 306 | $4.56 | $1.4K | 306 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise deriv | 2020-06-23 | 2020-06-24 | 2,115 | — | $0 | 74,480 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | S Sale | 2020-06-23 | 2020-06-24 | 2,115 | $35.23 | $74.5K | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise | 2020-06-23 | 2020-06-24 | 2,115 | $1.04 | $2.2K | 2,115 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise deriv | 2020-06-01 | 2020-06-02 | 1,000 | — | $0 | 68,340 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | S Sale | 2020-06-01 | 2020-06-02 | 1,000 | $25.32 | $25.3K | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise | 2020-06-01 | 2020-06-02 | 1,000 | $4.56 | $4.6K | 1,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise deriv | 2020-05-20 | 2020-05-21 | 2,000 | — | $0 | 69,340 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise | 2020-05-20 | 2020-05-21 | 2,000 | $4.56 | $9.1K | 2,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | S Sale | 2020-05-20 | 2020-05-21 | 2,000 | $25.00 | $50.0K | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise deriv | 2020-03-11 | 2020-03-12 | 1,000 | — | $0 | 71,340 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | S Sale | 2020-03-11 | 2020-03-12 | 1,000 | $27.68 | $27.7K | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | M Exercise | 2020-03-11 | 2020-03-12 | 1,000 | $4.56 | $4.6K | 1,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-03-04 | 2020-03-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-08-15 | 2018-08-17 | 14,050 | — | $0 | 14,050 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2018-08-15 | 2018-08-17 | 21,100 | — | $0 | 30,560 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-02-28 | 2018-03-02 | 34,000 | — | $0 | 34,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2018-02-28 | 2018-03-02 | 6,000 | — | $0 | 8,858 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-12-18 | 2017-12-20 | 4,000 | — | $0 | 28,998 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-12-18 | 2017-12-20 | 4,000 | — | $0 | 57,666 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-12-18 | 2017-12-20 | 4,000 | $4.21 | $16.8K | 8,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-12-18 | 2017-12-20 | 4,000 | $1.16 | $4.6K | 4,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-12-18 | 2017-12-20 | 8,000 | $20.00 | $160.0K | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2016-10-11 | 2016-10-13 | 45,000 | — | $0 | 45,000 | SEC↗ |